Evaluation of Small Molecule Combinations against Respiratory Syncytial Virus In Vitro
Respiratory syncytial virus (RSV) is a major pathogen that causes severe lower respiratory tract infection in infants, the elderly and the immunocompromised worldwide. At present no approved specific drugs or vaccines are available to treat this pathogen. Recently, several promising candidates targe...
Main Authors: | Yuzhen Gao, Jingjing Cao, Pan Xing, Ralf Altmeyer, Youming Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/9/2607 |
Similar Items
-
Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus
by: Jie Yuan, et al.
Published: (2020-07-01) -
Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach
by: Satabdi Saha, et al.
Published: (2021-02-01) -
Structure of the RSV Polymerase Complex Reveals a Tentacular Arrangement of the Viral Phosphoprotein
by: Jason S. McLellan
Published: (2020-07-01) -
Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities
by: Sveva Pelliccia, et al.
Published: (2017-01-01) -
Structural Characterization of Non-structural Protein 9 Complexed With Specific Nanobody Pinpoints Two Important Residues Involved in Porcine Reproductive and Respiratory Syndrome Virus Replication
by: Yan Wang, et al.
Published: (2020-11-01)